Sangamo Therapeutics (SGMO) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
EPS Growth %: +25.0%
Financial Fact:
Net loss: -18.97M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +25.0%
Financial Fact:
Net loss: -18.97M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Sangamo Therapeutics (NASDAQ: SGMO) reported Q1 EPS of ($0.30), $0.01 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $28.2 million versus the consensus estimate of $27.29 million.
For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
- After-Hours Stock Movers: FDX, CBRS, NKE
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
